| 000 | 01408 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250510200249.0 | ||
| 264 | 0 | _c19781018 | |
| 008 | 197810s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(78)90258-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aU'Prichard, D C | |
| 245 | 0 | 0 |
_aPrazosin: differential affinities for two populations of alpha-noradrenergic receptor binding sites. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJul 1978 |
||
| 300 |
_a87-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aClonidine _xmetabolism |
| 650 | 0 | 4 |
_aDihydroergotoxine _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhenoxybenzamine _xpharmacology |
| 650 | 0 | 4 |
_aPhentolamine _xpharmacology |
| 650 | 0 | 4 |
_aPrazosin _xpharmacology |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Adrenergic _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xdrug effects |
| 700 | 1 | _aCharness, M E | |
| 700 | 1 | _aRobertson, D | |
| 700 | 1 | _aSnyder, S H | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 50 _gno. 1 _gp. 87-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(78)90258-3 _zAvailable from publisher's website |
| 999 |
_c27304 _d27304 |
||